Загрузка...
Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective
Background: Little is known about the costs associated with vitamin K antagonist (VKA) treatment in patients with non-valvular atrial fibrillation (NVAF) in France. Objectives: To evaluate monthly per-patient costs attributable to VKA treatment in NVAF patients from a French societal perspective. St...
Сохранить в:
| Опубликовано в: : | J Mark Access Health Policy |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Routledge
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6374971/ https://ncbi.nlm.nih.gov/pubmed/30788086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2018.1564506 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|